We have developed a unique platform technology, SMARTChip, for producing biosensors aimed at providing point-of-care diagnostics (POCD).
SMARTChip will enable, for the first time, physiological information to be obtained to complement clinical assessment of conditions such as stroke, traumatic brain injury (TBI), heart attacks, limb ischaemia and foetal hypoxia. SMARTChip will thus allow such assessments to be made at the point-of-care (POC) setting.
A key advantage is the ability to rapidly detect biological markers of trauma or disease at levels too low to be measured by competitor technologies, and without the need for time-consuming sample preparation and laboratory analysis.
Next PostResearch Products »